ARVN
Arvinas Inc
Price:  
8.45 
USD
Volume:  
908,423.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arvinas EV/EBITDA

-115.6%
Upside

As of 2026-09-13, the EV/EBITDA ratio of Arvinas Inc (ARVN) is -32.93. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Arvinas's latest enterprise value is 451.19 mil USD. Arvinas's TTM EBITDA according to its financial statements is -13.70 mil USD. Dividing these 2 quantities gives us the above Arvinas EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.9x - 16.4x 12.0x
Forward P/E multiples 12.0x - 15.7x 14.2x
Fair Price (1.08) - (1.87) (1.31)
Upside -112.8% - -122.1% -115.6%
8.45 USD
Stock Price
(1.31) USD
Fair Price

Arvinas EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-09-11 -32.93
2026-09-10 -34.16
2026-09-09 -34.39
2026-09-08 -35.90
2026-09-04 -37.36
2026-09-03 -36.98
2026-09-02 -38.30
2026-09-01 -36.84
2026-08-31 -36.47
2026-08-28 -36.37
2026-08-27 -36.65
2026-08-26 -37.03
2026-08-25 -38.35
2026-08-24 -37.13
2026-08-21 -37.24
2026-08-20 -35.64
2026-08-19 -38.73
2026-08-18 -36.75
2026-08-17 -36.47
2026-08-14 -35.38
2026-08-13 -35.57
2026-08-12 -34.91
2026-08-11 -35.48
2026-08-10 -35.48
2026-08-07 -34.35
2026-08-06 -34.02
2026-08-05 -32.70
2026-08-04 -35.52
2026-08-03 -31.10
2026-07-31 -30.96
2026-07-30 -32.23
2026-07-29 -31.85
2026-07-28 -31.76
2026-07-27 -31.85
2026-07-24 -30.96
2026-07-23 -31.38
2026-07-22 -32.04
2026-07-21 -32.04
2026-07-20 -30.91
2026-07-17 -30.86
2026-07-16 -30.96
2026-07-15 -32.13
2026-07-14 -32.09
2026-07-13 -31.29
2026-07-10 -32.09
2026-07-09 -33.36
2026-07-08 -33.45
2026-07-07 -33.59
2026-07-06 -32.93
2026-07-02 -32.65